Clinical Trial

A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.

Name: A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects. — clinical trial record (NCT06839131)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of the study is to evaluate the safety of SPH9788 tablets in healthy subjects.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-02-18; most recent amendment 2026-04-29.

Trial Details

NCT Number	NCT06839131
Lead Sponsor	Shanghai Pharmaceuticals Holding Co., Ltd
Conditions	Healthy Participants
Enrollment	94 participants
Start Date	2025-03-02
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-05